Procter & Gamble Raises All-In Sales Growth Outlook to 2%-4%
The company raised its prior outlook range of 1%-3% growth. The increase reflects its acquisition of Thorne Healthtech, which closed Oct. 1.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.